Khan Maryam Ali, Abdelkarim Ahmed, Elsayed Nadin, Chow Christopher Yu, Cajas-Monson Luis, Malas Mahmoud B
Division of Vascular and Endovascular Surgery, University of California San Diego, San Diego, CA.
Division of Vascular and Endovascular Surgery, University of California San Diego, San Diego, CA.
J Vasc Surg. 2023 Jan;77(1):191-200. doi: 10.1016/j.jvs.2022.08.030. Epub 2022 Aug 30.
Carotid endarterectomy is relatively contraindicated in patients with a hostile neck anatomy who were historically revascularized with transfemoral carotid artery stenting (TFCAS). As transcarotid artery revascularization (TCAR) has progressively replaced TFCAS, evidence pertaining to hostile neck anatomy and TCAR is necessary to establish its safety and feasibility in this subgroup of patients. Therefore, we analyzed the impact of a hostile neck anatomy on outcomes in patients undergoing TCAR and further compared them with those undergoing TFCAS to establish recommendations for standard of care.
All patients undergoing TCAR and TFCAS from November 2016 to June 2021 in the Vascular Quality Initiative database were included. Patients were characterized into two groups based on the neck anatomy. Hostile neck anatomy was defined as a history of neck radiation or prior neck surgery including prior carotid endarterectomy or radical neck dissection. Primary outcomes included technical failure, access site complications (hematoma, stenosis, infection, pseudoaneurysm and arteriovenous fistula), and stroke or death. Secondary outcomes included stroke, transient ischemic attack (TIA), myocardial infarction (MI), death, and a composite end point of stroke or TIA. Patients with nonatherosclerotic or multiple lesions were excluded from the analysis. Primary analysis was performed with all patients undergoing TCAR and outcomes between patients with hostile and nonhostile neck anatomy were compared. Further analysis included a comparison of patients with a hostile neck anatomy undergoing TCAR and TFCAS. Univariable and multivariable logistic regression was used to assess impact of hostile neck anatomy on postoperative outcomes. Results were adjusted for relevant potential confounders including age, gender, race, degree of stenosis, symptomatic status, comorbidities, preoperative medications, anesthesia type, and protamine use.
Among the 19,859 patients who underwent TCAR during the study period, 3636 (18.3%) had a hostile neck anatomy. On univariate analysis, both groups had comparable outcomes except for higher rates of stroke or death in patients with hostile neck anatomy. After adjusting for potential confounders, there were no differences in technical failure (adjusted odds ratio [aOR], 1.14; 95% confidence interval [CI], 0.59-2.21; P = .699), stroke (aOR, 0.86; 95% CI, 0.58-1.28; P = .464), death (aOR, 0.82; 95% CI, 0.39-1.71; P = .598), and MI (aOR, 1.18; 95% CI, 0.71-1.97; P = .518). However, patients with hostile neck were at a 30% increased risk of access site complications (aOR, 1.30; 95% CI, 1.0-1.6; P = .023). Further adjusted analysis comparing the outcomes in TFCAS and TCAR among patients with hostile neck anatomy showed an almost four-fold increase in risk of death (aOR, 3.77; 95% CI, 1.49-9.53; P = .005) and technical failure (aOR, 3.69; 95% CI, 1.82-7.47; P < .001) among patients undergoing treatment with TFCAS.
Patients with a hostile neck anatomy undergoing TCAR experienced an increased risk of access site complications; however, the risk for technical failure and postoperative stroke/death, stroke, TIA, MI, or death was similar among both groups. TFCAS was associated with significant increase in the risk of death and technical failure compared with TCAR in this group of patients. These results confirm that TCAR should be the preferred minimally invasive revascularization procedure for patients with hostile neck anatomy.
对于颈部解剖结构复杂的患者,传统上采用经股动脉颈动脉支架置入术(TFCAS)进行血管重建,而颈动脉内膜切除术相对禁忌。随着经颈动脉血管重建术(TCAR)逐渐取代TFCAS,有必要获取有关颈部解剖结构复杂与TCAR的证据,以确定其在该亚组患者中的安全性和可行性。因此,我们分析了颈部解剖结构复杂对接受TCAR患者预后的影响,并进一步将其与接受TFCAS的患者进行比较,以制定护理标准建议。
纳入2016年11月至2021年6月在血管质量倡议数据库中接受TCAR和TFCAS的所有患者。根据颈部解剖结构将患者分为两组。颈部解剖结构复杂定义为有颈部放疗史或既往颈部手术史,包括既往颈动脉内膜切除术或根治性颈清扫术。主要结局包括技术失败、穿刺部位并发症(血肿、狭窄、感染、假性动脉瘤和动静脉瘘)以及卒中或死亡。次要结局包括卒中、短暂性脑缺血发作(TIA)、心肌梗死(MI)、死亡以及卒中或TIA的复合终点。排除非动脉粥样硬化或多发病变患者。对所有接受TCAR的患者进行初步分析,并比较颈部解剖结构复杂和不复杂患者的结局。进一步分析包括比较接受TCAR和TFCAS的颈部解剖结构复杂患者。采用单变量和多变量逻辑回归评估颈部解剖结构复杂对术后结局的影响。结果针对包括年龄、性别、种族、狭窄程度、症状状态、合并症、术前用药、麻醉类型和鱼精蛋白使用等相关潜在混杂因素进行了调整。
在研究期间接受TCAR的19,859例患者中,3636例(18.3%)颈部解剖结构复杂。单变量分析显示,除颈部解剖结构复杂患者的卒中和死亡发生率较高外,两组结局相似。在调整潜在混杂因素后,技术失败(调整优势比[aOR],1.14;95%置信区间[CI],0.59 - 2.21;P = 0.699)、卒中(aOR,0.86;95% CI,0.58 - 1.28;P = 0.464)、死亡(aOR,0.82;95% CI,0.39 - 1.71;P = 0.598)和MI(aOR,1.18;95% CI,0.71 - 1.97;P = 0.518)方面无差异。然而,颈部解剖结构复杂的患者穿刺部位并发症风险增加30%(aOR,1.30;95% CI,1.0 - 1.6;P = 0.023)。进一步调整分析比较颈部解剖结构复杂患者中TFCAS和TCAR的结局,结果显示接受TFCAS治疗的患者死亡风险(aOR,3.77;95% CI,1.49 - 9.53;P = 0.005)和技术失败风险(aOR,3.69;95% CI,1.82 - 7.47;P < 0.001)几乎增加四倍。
接受TCAR的颈部解剖结构复杂患者穿刺部位并发症风险增加;然而,两组在技术失败、术后卒中和死亡、卒中、TIA、MI或死亡风险方面相似。与TCAR相比,该组患者中TFCAS与死亡和技术失败风险显著增加相关。这些结果证实,TCAR应是颈部解剖结构复杂患者首选的微创血管重建手术。